Center Laboratories, Inc. (TPEX: 4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
42.85
-0.75 (-1.72%)
Sep 10, 2024, 1:30 PM CST
-7.95%
Market Cap 30.58B
Revenue (ttm) 1.52B
Net Income (ttm) -1.67B
Shares Out 713.56M
EPS (ttm) -2.43
PE Ratio n/a
Forward PE n/a
Dividend 1.50 (3.44%)
Ex-Dividend Date Aug 2, 2024
Volume 1,082,520
Open 44.00
Previous Close 43.60
Day's Range 42.75 - 44.00
52-Week Range 40.10 - 59.60
Beta 0.83
Analysts n/a
Price Target n/a
Earnings Date Nov 12, 2024

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally. It engages in the research and development of small molecule drugs, as well as solutions for neurological and oncological diseases; development of proteins and antibodies; and pharmaceutical CDMO, medical device, software as medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment and venture capital businesses. The company also supplies glass ... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.